Company profile: FairJourney Biologics
1.1 - Company Overview
Company description
- Provider of end-to-end antibody discovery and development solutions, leveraging top-tier technologies and seasoned researchers to deliver high-quality, reliable antibodies tailored to partner needs. Services include customized cell line engineering for research and support from discovery to clinical trials; organizer of The Antibody Series on innovations in antibody discovery and development.
Products and services
- Antibody Discovery and Development: End-to-end system that architects antibodies from initial discovery through clinical trials, delivering tailored, reliable products using top-tier technologies and a team of seasoned researchers
- Cell Line Engineering: Custom-engineered service that builds research cell lines enabling study of biological processes, disease mechanisms, and drug targets, tailored to partners’ unique needs
- The Antibody Series: Industry-focused event that gathers experts in antibody discovery and development to discuss innovations and advancements in the field
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to FairJourney Biologics
Pro-Spectus
HQ: United States
Website
- Description: Provider of healthcare advisory services specializing in the pharmaceutical, medical device, and diagnostic healthcare industries, offering a Patient Access Program that enables patient and market access to therapies by optimizing the patient access journey.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pro-Spectus company profile →
Lexitas
HQ: United States
Website
- Description: Provider of full-service ophthalmology CRO solutions for pharma and biotech, including end-to-end clinical operations, global site relationships and international regulatory expertise, medical and regulatory writing, medical monitoring, reading center image assessments, and data management, biostatistics, and statistical programming.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lexitas company profile →
Medical Science & Computing
HQ: United States
Website
- Description: Provider of advanced data analytics and AI to support health, human services, and public safety missions; enterprise digital modernization and system integration; and cloud adoption and infrastructure optimization to enhance performance, reduce costs, improve public health, strengthen research and IT capabilities, and optimize operational outcomes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medical Science & Computing company profile →
AnovoRx
HQ: United States
Website
- Description: Provider of specialty pharmacy and access services for ultra-rare medications, offering 3PL/specialty distribution, patient support (benefits investigation, prior authorization and appeals, case management), reimbursement programs, clinical assessment and adherence management, adverse event reporting, and product complaint and recall management.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AnovoRx company profile →
Health Decisions
HQ: United States
Website
- Description: Provider of full-service contract research organization services specializing in clinical studies of therapeutics for women’s health and diagnostics across all therapeutic areas; focused on women’s health for over 28 years with more than 100 trials in women-only indications such as contraception, serving forward-looking biopharma and medical device companies and supporting modernization of clinical development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Health Decisions company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for FairJourney Biologics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to FairJourney Biologics
2.2 - Growth funds investing in similar companies to FairJourney Biologics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for FairJourney Biologics
4.2 - Public trading comparable groups for FairJourney Biologics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →